Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, T-Cell, Cutaneous

Explore clinical trials studying Lymphoma, T-Cell, Cutaneous. Study availability and eligibility vary by location and protocol.

389 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, T-Cell, Cutaneous trial results

Recruiting

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

NCT07192471

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
Locations
  • University of California, Irvine Medical Center - Hematology/Oncology Orange, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Beth Israel Deaconess Medical Center - Research Boston, Massachusetts, United States
  • Washington University School of Medicine - Oncology Hospital - Public St Louis, Missouri, United States
View all 22 locations
View Trial Details
Recruiting

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

NCT07195916

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +29 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • University of California San Diego Medical Center, Moores Cancer Center La Jolla, California, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • The University of Nebraska Medical Center Omaha, Nebraska, United States
View all 22 locations
View Trial Details
Recruiting

Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma

NCT03011814

Conditions
Folliculotropic Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Thomas Jefferson University Hospital Philadelphia, Pennsylvania, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions